Delivery Order SPE2DR25D3003-SPE2DR26F5QL5
- Not listed
- The Defense Logistics Agency awarded a $1,297.36 delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 unit/mL insulin in 3mL quantities, with an ultimate completion date of May 5, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,237.50 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for $2,872.47 on September 23, 2025. The order covers Lantus SoloStar 100 Unit/mL insulin in 3mL quantities and will be performed at the contractor's Conshohocken facility with an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin on November 7, 2025, with a ceiling value of $1,212.74 and an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $14,583.67 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL configurations. This firm fixed-price, competitively awarded delivery order is scheduled for completion by December 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all qualified...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.46 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin, with delivery scheduled to the contractor's corporate office location in Conshohocken, Pennsylvania. The award, issued on August 19, 2025, reflects a firm fixed-price delivery order with an ultimate completion date of August 20, 2025. No set-aside designation was applied to this competitive award, indicating the contract was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $7,495.44 to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lantus SoloStar insulin (100 unit/mL, 3mL formulation) with a ceiling value of $1,022.80. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award to the vendor. The contract is to be completed by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,775.19 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin products. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 15, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- SPE2DR25D3003Indefinite Delivery Contract
- SPE2DR25D3003-SPE2DR26F5QL5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,708.17 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ML quantities. The award was made on December 19, 2025, with a completion date of December 22, 2025, and represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement needs across multiple therapeutic domains, including diabetes medications, neurological treatments, antibiotics, and specialized medical supplies, positioning it as a critical vendor for Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/18/25 |